-
Countering false and misleading claims about Tylenol and autism from the top
Journalists across the U.S. have been scrambling to keep up with a firehose of health misinformation coming from the administration since Monday’s Health & Human Services news conference debacle. Plenty of publications have already done a fantastic job of addressing the false or misleading claims by HHS Secretary Robert Kennedy and President Trump and providing…
-
Preparing for reporting on autism, vaccines and related science
In this webinar, moderator Tara Haelle and an expert panel — including Paul Offit, M.D. (Children’s Hospital of Philadelphia), and Jessica B. Steier, DrPH, PMP (Founder and CEO of Unbiased Science) — help reporters navigate the science behind autism, vaccines, and the expected Health and Human Services report on autism causes. Facilitated by: Jesse Goodman, M.D., MPH, Chair of the E-VAT — Expert…
-
Researchers open up the conversation about diversity in autism case studies
Autism in the Hispanic population: A case study in adding diversity to clinical trials Moderator: Usha Lee McFarling, national science correspondent,STAT Bridget Fernandez, M.D., chief of medical genetics, Children’s Hospital Los Angeles Daniella Martello, clinical research coordinator, Hispanic Autism Genomics Project at the Children’s Hospital Los Angeles Liset Valdivias, family of study participant, Children’s Hospital…
-
Health Transformation Alliance Teams up With Cognoa for Autism Diagnostic Device
Health Transformation Alliance Teams up With Cognoa for Autism Diagnostic Device Cognoa’s Canvas Dx product is authorized by the Food and Drug Administration and assists healthcare providers in diagnosing autism spectrum disorder for children ages 18 months through 72 months. Members of Health Transformation Alliance can now add Canvas Dx to their benefit plans. Information…
Got any book recommendations?